Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma

NCT05757466 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Prolgolimab
DRUG: Combination with prolgolimab and bendamustine

Sponsor

St. Petersburg State Pavlov Medical University

Collaborators

[object Object]